In sum, it is evident that post-translational modifications can modulate LLPS and protein aggregation of the ALS proteins TDP-43 and FUS, yet their exact role in Matrin3 pathology remains to be clarified. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.